rs1554101177
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_005732.4(RAD50):c.3650T>C(p.Leu1217Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L1217L) has been classified as Likely benign.
Frequency
Consequence
NM_005732.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| RAD50 | NM_005732.4 | c.3650T>C | p.Leu1217Pro | missense_variant | Exon 24 of 25 | ENST00000378823.8 | NP_005723.2 | |
| TH2LCRR | NR_132124.1 | n.45+1043A>G | intron_variant | Intron 1 of 2 | ||||
| TH2LCRR | NR_132125.1 | n.189+1495A>G | intron_variant | Intron 2 of 2 | ||||
| TH2LCRR | NR_132126.1 | n.175-2438A>G | intron_variant | Intron 1 of 1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| RAD50 | ENST00000378823.8 | c.3650T>C | p.Leu1217Pro | missense_variant | Exon 24 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
| ENSG00000283782 | ENST00000638452.2 | c.3353T>C | p.Leu1118Pro | missense_variant | Exon 26 of 27 | 5 | ENSP00000492349.2 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome  AF:  0.00000137  AC: 2AN: 1461888Hom.:  0  Cov.: 32 AF XY:  0.00000138  AC XY: 1AN XY: 727246 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Uncertain:2 
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 1217 of the RAD50 protein (p.Leu1217Pro). This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RAD50 protein function. ClinVar contains an entry for this variant (Variation ID: 486245). This variant has not been reported in the literature in individuals affected with RAD50-related conditions. -
The p.L1217P variant (also known as c.3650T>C), located in coding exon 24 of the RAD50 gene, results from a T to C substitution at nucleotide position 3650. The leucine at codon 1217 is replaced by proline, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at